Krystal Biotech, Inc. (KRYS) Earnings
|
Expand Research on KRYS
| Next EPS Date | 8/10/26 | EPS Growth Rate | +32.6% |
|---|---|---|---|
| Average EPS % Beat Rate | +45.3% | Revenue Growth Rate | +28.2% |
| Average % Move 1-Wk after EPS | +0.7% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/10/26  |
Q226 | N/A | $1.71 | N/A | N/A | $123.1M | N/A | N/A | N/A | ||
| 5/4/26 | Q126 | $1.83 | $1.48 | +$0.35 | $116.36M | $111.47M | N/A |  | | Details | |
| 2/17/26 | Q425 | $1.70 | $1.58 | +$0.12 | $107.1M | $106.16M | N/A | | | Details | |
| 11/3/25 | Q325 | $2.66 | $1.09 | +$1.57 | $97.8M | $93.19M | N/A | | | Details | |
| 8/4/25 | Q225 | $1.29 | $1.22 | +$0.07 | $96.04M | $92.24M | N/A | | | Details | |
| 5/6/25 | Q125 | $1.20 | $1.46 | -$0.26 | $88.18M | $99.12M | N/A | | | Details | |
| 2/19/25 | Q424 | $1.52 | $1.21 | +$0.31 | $91.14M | $91.63M | N/A | | | Details | |
| 11/4/24 | Q324 | $0.91 | $0.99 | -$0.08 | $83.8M | $82.94M | N/A | | | Details |
